Applied Materials Stock Surges After Beat-And-Raise Earnings Report – Investor's Business Daily
BREAKING: Market Strong But Risks Rise With Powell On Tap
Semiconductor equipment vendor Applied Materials (AMAT) late Thursday easily beat Wall Street’s targets for its fiscal first quarter and guided higher than estimates for the current period. AMAT stock surged in extended trading.
The Santa Clara, Calif.-based company earned an adjusted $2.13 a share on sales of $6.71 billion in the quarter ended Jan. 28. Analysts polled by FactSet had expected earnings of $1.90 a share on sales of $6.48 billion. On a year-over-year basis, Applied Materials earnings rose 5% while sales dipped a fraction.
For the current quarter, Applied Materials forecast adjusted earnings of $1.97 a share on sales of $6.5 billion. That’s based on the midpoint of its guidance. Analysts had been looking for earnings of $1.80 a share on sales of $6.34 billion. In the year-earlier period, its adjusted earnings were $2 a share on sales of $6.63 billion.
“Applied Materials delivered strong results in the first quarter of fiscal 2024 and has outperformed our markets for the fifth consecutive year,” Chief Executive Gary Dickerson said in a news release.
He added, “Our leadership positions at key semiconductor inflections support continued outperformance as customers ramp next-generation chip technologies critical to AI (artificial intelligence) and IoT (Internet of Things) over the next several years.”
In after-hours trading on the stock market today, AMAT stock jumped more than 10% to 207.90. During the regular session Thursday, AMAT stock rose 0.8% to close at 187.66.
On Nov. 10, AMAT stock broke out of a double-bottom base at a buy point of 148.40, according to IBD MarketSmith charts. In intraday trading on Thursday, AMAT stock notched a regular-session record high of 189.47.
AMAT stock is on the IBD Tech Leaders list.
Follow Patrick Seitz on X, formerly Twitter, at @IBD_PSeitz for more stories on consumer technology, software and semiconductor stocks.
YOU MAY ALSO LIKE:
InterDigital, IBD Stock Of The Day, Surprises With Big Beat-And-Raise Report
Super Micro Computer Extends Dizzying Climb On Bullish Report
Semiconductor Market Starting To Recover, Chip Gear Maker Says
Find Today’s Best Growth Stocks To Watch With IBD 50
See Stocks On The List Of Leaders Near A Buy Point
6/27/2024 Applied Materials and Lam Research saw their shares rise after memory-chip maker Micron forecast a sizable increase in capital spending.
6/27/2024 Applied Materials and Lam Research saw their shares rise after…
Statins have long been the de facto treatment for high LDL cholesterol. New approaches promise safer and more effective ways to reduce “bad” cholesterol for people who are at risk of cardiovascular problems. (ElizabethGessel/TarikVision/Shutterstock)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2024 Investor’s Business Daily, LLC. All rights reserved
